• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1对组织型纤溶酶原激活物诱导的纤维蛋白溶解的影响。

Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.

作者信息

Carr M E, Krishnamurti C, Alving B M

机构信息

Medical Service, McGuire Veterans Administration Hospital, Richmond, VA 23249.

出版信息

Thromb Haemost. 1992 Jan 23;67(1):106-10.

PMID:1615464
Abstract

The effect of fibrin on the interaction of human recombinant single-chain tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) was studied in normal rabbit plasma and in plasma with high levels of native PAI-1. t-PA was added to diluted plasma containing calcium (10 mM) and 125I-fibrinogen at 37 degrees C. Clotting was initiated with human thrombin, and lysis was monitored both turbidimetrically and by release of 125I-fibrin degradation products (fdp). The activity of t-PA (50 IU/ml) was rapidly reduced to 15% of the initial value in plasma containing PAI-1 (23 AU/ml). When thrombin and t-PA were added simultaneously to the plasma, more than 70% of the activity was retained through incorporation of t-PA into the fibrin clot. t-PA-induced fibrinolysis in PAI-1 enriched plasma was further delayed when the temperature was reduced from 37 to 25 degrees C. Turbidimetric and 125I-fdp release data provided complementary information. The former technique traced fiber dissolution, while the latter reflected network integrity. These results indicate that t-PA-induced fibrinolysis in PAI-1 enriched plasma is modulated by the presence of fibrin and by temperature.

摘要

在正常兔血浆和含有高水平天然纤溶酶原激活物抑制剂-1(PAI-1)的血浆中,研究了纤维蛋白对人重组单链组织型纤溶酶原激活物(t-PA)与纤溶酶原激活物抑制剂-1(PAI-1)相互作用的影响。将t-PA加入到含有钙(10 mM)和125I-纤维蛋白原的稀释血浆中,于37℃孵育。用人凝血酶启动凝血,并通过比浊法和125I-纤维蛋白降解产物(fdp)的释放来监测纤维蛋白溶解。在含有PAI-1(23 AU/ml)的血浆中,t-PA(50 IU/ml)的活性迅速降至初始值的15%。当同时将凝血酶和t-PA加入血浆时,通过将t-PA掺入纤维蛋白凝块中,超过70%的活性得以保留。当温度从37℃降至25℃时,PAI-1富集血浆中t-PA诱导的纤维蛋白溶解进一步延迟。比浊法和125I-fdp释放数据提供了互补信息。前一种技术追踪纤维溶解,而后一种技术反映网络完整性。这些结果表明,PAI-1富集血浆中t-PA诱导的纤维蛋白溶解受纤维蛋白的存在和温度的调节。

相似文献

1
Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.纤溶酶原激活物抑制剂-1对组织型纤溶酶原激活物诱导的纤维蛋白溶解的影响。
Thromb Haemost. 1992 Jan 23;67(1):106-10.
2
Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.活化蛋白C对内毒素处理家兔组织型纤溶酶原激活剂诱导纤溶的增强作用
J Lab Clin Med. 1991 Dec;118(6):523-30.
3
Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.高度稳定的1型纤溶酶原激活物抑制剂(VLHL PAI-1)可保护纤维蛋白凝块免受组织纤溶酶原激活物介导的纤维蛋白溶解作用。
Int J Mol Med. 2007 Nov;20(5):683-7.
4
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.与纤维蛋白结合的1型纤溶酶原激活物抑制剂(PAI-1)与组织型纤溶酶原激活物(t-PA)或尿激酶型纤溶酶原激活物(u-PA)之间的相互作用。t-PA的指状结构域和kringle-2结构域介导t-PA/PAI-1复合物与纤维蛋白的结合。
J Clin Invest. 1989 Aug;84(2):647-55. doi: 10.1172/JCI114211.
5
Biochemical and biological properties of a recombinant tissue-type plasminogen activator derived from the rat JMI-229 cell line.源自大鼠JMI-229细胞系的重组组织型纤溶酶原激活剂的生化及生物学特性
Thromb Haemost. 1992 Feb 3;67(2):239-47.
6
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
7
Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.内毒素诱导的兔血管内凝血:组织型纤溶酶原激活物与尿激酶对纤溶酶原激活物抑制物生成、纤维蛋白沉积及死亡率的影响
Thromb Haemost. 1995 Dec;74(6):1578-82.
8
Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.纤溶酶原激活物快速作用抑制剂对兔体内组织型纤溶酶原激活物诱导的溶栓作用的影响。组织源性成分的干扰。
J Clin Invest. 1986 Jul;78(1):138-44. doi: 10.1172/JCI112543.
9
Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.可溶性纤维蛋白降解产物增强组织型纤溶酶原激活物诱导的纤维蛋白原蛋白水解作用。
J Clin Invest. 1991 Mar;87(3):1082-90. doi: 10.1172/JCI115069.
10
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.

引用本文的文献

1
Application of long-acting VLHL PAI-1 during sutureless partial nephrectomy in mice reduces bleeding.在小鼠无缝合部分肾切除术中应用长效VLHL PAI-1可减少出血。
Biomed Res Int. 2015;2015:392862. doi: 10.1155/2015/392862. Epub 2015 Mar 26.
2
Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1.出血素质与纤溶酶原激活物抑制剂1型第2外显子中的A15T杂合突变相关。
Exp Ther Med. 2010 Jul;1(4):575-577. doi: 10.3892/etm_00000090. Epub 2010 Jul 1.
3
Inner clot diffusion and permeation during fibrinolysis.
纤维蛋白溶解过程中的内部凝块扩散与渗透。
Biophys J. 1993 Dec;65(6):2622-43. doi: 10.1016/S0006-3495(93)81314-6.